There have been several products developed for male sexual dysfunction. However, developing agents for female sexual dysfunction is lagging behind for various reasons. Sildenafil citrate (Viagra) and Tadalafil (Cialis), which have been prescribed for male sexual function disorders, are known to act on vessels.
Introduction of Flibanserin
From now on, molecular study regarding female sexuality has focused on female sexual hormone, like estrogen receptor (ER) and ER derivatives. Stage 2b studies have failed to prove its general effectiveness on depression, but in answering this question "How intense is your sexual desire?" in the ASEX, flibanserin turned out to be more excellent in both placebo and active-comparator.
Since then, drug development has changed its directivity toward being a potential medicine for treating hypoactive sexual desire disorder (HSDD).
Diagnostic Criteria of HSDD
HSDD is characterized by constant and repeated lack or absence of sexual fantasy and sexual desire associated with personal pain in the 4th edition of the Diagnostic and Statistical Manual-Text Revision (DSM-IV-TR). for male sexual function disorder were already approved. in case that sexual desire disorder comes from disease, psychiatric problems, and interpersonal problems or in case that it does so from medications or other substances taken in conjunction, these cases are not the diseases for which medicine is efficacious. Besides, postmenopausal women and sexual desire decline disorder male patients are not adapted during use and it is not intended for reinforcing sexuality.
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